Evidence map›Paper›PMID 30788337›Full record

ArticleFrontiers in pediatrics2019

Sertraline Pharmacokinetics in HIV-Infected and Uninfected Children, Adolescents, and Young Adults.

Nathan John Hanan, Mary Elizabeth Paul, Yanling Huo, Suad Kapetanovic, Elizabeth Smith, George Siberry, Pim Brouwers, Bobbie Graham, Benjamin Johnston, Edmund V Capparelli and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

Nathan John HananDepartment of Pediatrics-Rady Children's Hospital San Diego, University of California, San Diego, San Diego, CA, United States.
Mary Elizabeth PaulDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, United States.
Yanling HuoCenter for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
Suad KapetanovicDepartment of Psychiatry, University of Southern California, Los Angeles, CA, United States.
Elizabeth SmithMaternal, Adolescent, and Pediatric Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States.
George SiberryMaternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, United States.
Pim BrouwersDivision of AIDS Research, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.
Bobbie GrahamFrontier Science and Technology Research Foundation, Buffalo, NY, United States.
Benjamin JohnstonFrontier Science and Technology Research Foundation, Buffalo, NY, United States.
Edmund V CapparelliDepartment of Pediatrics-Rady Children's Hospital San Diego, University of California, San Diego, San Diego, CA, United States.
Brookie M BestDepartment of Pediatrics-Rady Children's Hospital San Diego, University of California, San Diego, San Diego, CA, United States.
Frontier Science & Technology Research Foundation · USUniversity of California, San Diego · USBaylor College of Medicine · USCancer Research And Biostatistics · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USNational Institute of Allergy and Infectious Diseases · USOffice of AIDS Research · USRady Children's Hospital-San Diego · USUniversity of Southern California · US

Funding

LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the USUM1AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI Sharon A Nachman · 2011 to 2026
$278.1M
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTGUM1AI068616 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Sean Scott Brummel, Marlene Ann Cooper · 2011 to 2026
$155.6M
LC - IMPAACT Leadership GroupUM1AI106716 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$47.2M
University of California, San Diego Clinical Trial UnitUM1AI069536 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STEPHEN A SPECTOR · 2012 to 2026
$34.0M
Developing Pediatric Clinical Pharmacologists for the Advancement of TherapeuticsT32HD087978 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR, TREMOULET, ADRIANA H · 2016 to 2025
$1.5M
NIAID NIH HHS UM1 AI068616NIAID NIH HHS UM1 AI068632NIAID NIH HHS UM1 AI069536NIAID NIH HHS UM1 AI106716NICHD NIH HHS T32 HD087978
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antiretroviralsHIVpediatricspharmacokineticssertraline

Identifiers

PMID30788337
PMCPMC6372542
OpenAlexW2911694999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.